Urmi Khanna

502 total citations
31 papers, 202 citations indexed

About

Urmi Khanna is a scholar working on Epidemiology, Dermatology and Pathology and Forensic Medicine. According to data from OpenAlex, Urmi Khanna has authored 31 papers receiving a total of 202 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 11 papers in Dermatology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Urmi Khanna's work include Autoimmune Bullous Skin Diseases (7 papers), Autoimmune and Inflammatory Disorders (7 papers) and Eosinophilic Disorders and Syndromes (5 papers). Urmi Khanna is often cited by papers focused on Autoimmune Bullous Skin Diseases (7 papers), Autoimmune and Inflammatory Disorders (7 papers) and Eosinophilic Disorders and Syndromes (5 papers). Urmi Khanna collaborates with scholars based in United States and India. Urmi Khanna's co-authors include Anthony P. Fernandez, Sujay Khandpur, Jeffrey P. North, Yumeng Li, Fabrizio Galimberti, Florian Rieder, Joseph Sleiman, Abhinav Jaimini, Shikha Arora and Himanshu Gupta and has published in prestigious journals such as The American Journal of Gastroenterology, Journal of the American Academy of Dermatology and Lara D. Veeken.

In The Last Decade

Urmi Khanna

30 papers receiving 200 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Urmi Khanna United States 9 95 75 39 36 27 31 202
Sonia Chávez‐Álvarez Mexico 7 87 0.9× 57 0.8× 21 0.5× 30 0.8× 19 0.7× 39 191
F. Hali Morocco 6 63 0.7× 49 0.7× 26 0.7× 23 0.6× 42 1.6× 96 164
Sanjiv Choudhary India 9 73 0.8× 69 0.9× 35 0.9× 36 1.0× 14 0.5× 50 203
Teresa Baudrier Portugal 10 56 0.6× 45 0.6× 53 1.4× 14 0.4× 33 1.2× 34 199
Justyna Sicińska Poland 10 123 1.3× 108 1.4× 19 0.5× 30 0.8× 48 1.8× 18 281
Minerva Gómez‐Flores Mexico 8 115 1.2× 66 0.9× 26 0.7× 17 0.5× 52 1.9× 25 238
S Ragunatha India 8 80 0.8× 58 0.8× 14 0.4× 35 1.0× 38 1.4× 25 183
Mustafa Turhan Şahin Türkiye 10 213 2.2× 58 0.8× 30 0.8× 41 1.1× 27 1.0× 18 296
Jennifer A. Cafardi United States 7 53 0.6× 86 1.1× 76 1.9× 30 0.8× 12 0.4× 9 224
E. Bahloul Tunisia 7 61 0.6× 30 0.4× 63 1.6× 16 0.4× 52 1.9× 65 205

Countries citing papers authored by Urmi Khanna

Since Specialization
Citations

This map shows the geographic impact of Urmi Khanna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Urmi Khanna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Urmi Khanna more than expected).

Fields of papers citing papers by Urmi Khanna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Urmi Khanna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Urmi Khanna. The network helps show where Urmi Khanna may publish in the future.

Co-authorship network of co-authors of Urmi Khanna

This figure shows the co-authorship network connecting the top 25 collaborators of Urmi Khanna. A scholar is included among the top collaborators of Urmi Khanna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Urmi Khanna. Urmi Khanna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khanna, Urmi, et al.. (2023). Tranexamic acid in melasma: A focused review on drug administration routes. Journal of Cosmetic Dermatology. 22(4). 1197–1206. 30 indexed citations
2.
Fernandez, Anthony P., et al.. (2023). Efficacy and safety of repository corticotropin injection for refractory cutaneous dermatomyositis: a prospective, open-label study. Lara D. Veeken. 63(12). 3370–3379. 1 indexed citations
3.
Sleiman, Joseph, Muhammad Zarrar Khan, Benjamin L. Cohen, et al.. (2023). Sweet Syndrome Associated with Active Inflammatory Bowel Disease: A Case Series of a Rare Extra-intestinal Manifestation. Digestive Diseases and Sciences. 68(9). 3562–3568. 1 indexed citations
4.
Bishnoi, Anuradha, et al.. (2023). Update for dermatologists on monkeypox: An emerging health problem in the world. Indian Journal of Dermatology Venereology and Leprology. 89(2). 326–331. 1 indexed citations
5.
Khanna, Urmi, et al.. (2022). Pentoxifylline in dermatology. Journal of Cosmetic Dermatology. 22(2). 410–417. 3 indexed citations
6.
Khanna, Urmi, et al.. (2022). Meyerson phenomenon in a nevus simplex. Indian Dermatology Online Journal. 14(1). 133–133.
8.
Khanna, Urmi, et al.. (2022). Painful perianal rash in an HIV-positive individual. JAAD Case Reports. 31. 115–117. 1 indexed citations
9.
Khanna, Urmi, et al.. (2022). New diagnosis of systemic lupus erythematosus after COVID-19 vaccination: A case report and review of literature. JAAD Case Reports. 30. 30–34. 8 indexed citations
10.
Khanna, Urmi, Fabrizio Galimberti, Yumeng Li, & Anthony P. Fernandez. (2021). Dermatomyositis and malignancy: should all patients with dermatomyositis undergo malignancy screening?. Annals of Translational Medicine. 9(5). 432–432. 19 indexed citations
11.
Khanna, Urmi, et al.. (2021). AB008. Utility of repeat latent tuberculosis testing in patients with immune-mediated diseases taking biologics. Annals of Translational Medicine. 9(5). AB008–AB008. 1 indexed citations
12.
Khanna, Urmi, et al.. (2020). Conversion to positive latent tuberculosis infection status is low in patients with hidradenitis suppurativa taking biologic medications. Journal of the American Academy of Dermatology. 83(1). 246–248. 5 indexed citations
13.
Nowacki, Amy S., et al.. (2020). Family history of psoriasis, psychological stressors, and tobacco use are associated with the development of tumor necrosis factor-α inhibitor-induced psoriasis: A case-control study. Journal of the American Academy of Dermatology. 83(6). 1599–1605. 13 indexed citations
14.
Khanna, Urmi, et al.. (2020). Safety of trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia prophylaxis in patients taking methotrexate. Journal of the American Academy of Dermatology. 84(1). 166–168. 4 indexed citations
15.
Khanna, Urmi, et al.. (2020). Quantitative Assessment of Eosinophils in Dermatomyositis Skin Biopsies With Correlation of Eosinophils to Pruritus and Other Clinical Features. American Journal of Dermatopathology. 43(4). 287–290. 5 indexed citations
16.
Billings, Steven D., Urmi Khanna, Christine Warren, et al.. (2019). Diagnoses of hospitalized patients with skin abnormalities prompting biopsy by consulting dermatologists: A 3‐year review from a tertiary care center. Journal of Cutaneous Pathology. 47(4). 346–356. 5 indexed citations
17.
Khanna, Urmi, et al.. (2019). A photo-distributed papulopustular eruption and multiple squamous cell carcinomas in a patient on ruxolitinib. JAAD Case Reports. 5(10). 895–897. 5 indexed citations
18.
Khandpur, Sujay & Urmi Khanna. (2019). What is new in narrow-band ultraviolet-B therapy for vitiligo?. Indian Dermatology Online Journal. 10(3). 234–234. 20 indexed citations
19.
Mondal, Anupam, et al.. (2014). Tuberculosis the great mimicker: 18F-fludeoxyglucose positron emission tomography/computed tomography in a case of atypical spinal tuberculosis. Indian Journal of Nuclear Medicine. 29(2). 99–99. 11 indexed citations
20.
Khanna, Urmi, et al.. (2014). Keloidal plaque in a patient with pulmonary tuberculosis: A rare morphological variant of tuberculosis verrucosa cutis. International Journal of Mycobacteriology. 3(3). 214–216. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026